NASDAQ: SGRYSurgery Partners Inc Stock Ownership
Insider buying vs selling
Have Surgery Partners Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Laura L. Brocklehurst | Chief Human Resources Officer | 2021-09-29 | 80 | $41.73 | $3.34kSell |
| Laura L. Brocklehurst | Chief Human Resources Officer | 2021-08-31 | 104 | $49.00 | $5.10kSell |
| Teresa Deluca | Director | 2021-08-10 | 2,000 | $46.70 | $93.40kBuy |
| Laura L. Brocklehurst | Chief Human Resources Officer | 2021-06-29 | 126 | $66.88 | $8.43kSell |
| Teresa Deluca | Director | 2021-06-09 | 5,035 | $63.67 | $320.58kSell |
| Teresa Deluca | Director | 2021-06-08 | 2,633 | $63.05 | $166.01kSell |
| George Goodwin | President ASC Group | 2021-05-17 | 31,000 | $52.00 | $1.61MSell |
| Anthony Taparo | Chief Growth Officer | 2021-05-10 | 63,588 | $50.55 | $3.21MSell |
| Jennifer Baldock | Chief Admin & Dev Officer | 2021-05-07 | 4,194 | $51.86 | $217.50kSell |
| Thomas F. Cowhey | Chief Financial Officer | 2021-05-06 | 25,000 | $52.28 | $1.31MSell |
SGRY insiders have sold more... subscribe to Premium to read more.
Ownership
SGRY Shareholders
What type of owners hold Surgery Partners Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Capital Investors Llc Bain | 91.61% | 75,520,227 | $3.32B | Insider |
| T. Devin Oreilly | 59.52% | 49,064,576 | $2.16B | Insider |
| Bain Capital Investors LLC | 59.52% | 49,064,576 | $2.16B | Institution |
| C. HR Istopher R. Gordon | 32.09% | 26,455,651 | $1.16B | Insider |
| Fmr LLC | 9.01% | 7,424,845 | $326.69M | Institution |
| Clearbridge Investments LLC | 4.32% | 3,557,873 | $156.55M | Institution |
| Michael Thomas Doyle | 3.79% | 3,122,474 | $137.39M | Insider |
| Vanguard Group Inc | 3.77% | 3,110,445 | $136.86M | Institution |
| Price T Rowe Associates Inc | 3.06% | 2,525,436 | $111.12M | Institution |
| Blackrock Inc | 2.42% | 1,997,837 | $87.90M | Institution |
Surgery Partners Stock Ownership FAQ
©2022 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.